In this webinar, Ania Jastreboff, MD, PhD, will discuss current use of anti-obesity pharmacotherapy, mechanisms involved, and agents in various stages of development with considerations for next steps. The presentation aims to inspire development of innovative therapeutics while optimizing use of existing agents to address the urgent need to effectively and sustainable treat millions of individuals with obesity around the world. Key topics will include: 1. understand the role of anti-obesity pharmacotherapy in the treatment of obesity, 2, describing current anti-obesity pharmacotherapy, and 3. discussing anti-obesity medications under development.